Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons

Cellular and Molecular Life Sciences

Volumn 57, Issue 10, 2000, Pages 1471-1481

  De la Monte, S M ^a   Neely, T R ^a   Cannon, J ^a   Wands, J R ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Mitochondria; Neuritic sprouting; Neurodegeneration; Oxidative stress

Indexed keywords

DEFEROXAMINE; HYDROGEN PEROXIDE; MITOCHONDRIAL DNA; MUTANT PROTEIN; NEUROMODULIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; GENE EXPRESSION; HYPOXIA; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

ANIMALIA;

EID: 0033769804     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000630     Document Type: Article

References (44)

1. Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress
2. Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenyl-hydrazine
3. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide
4. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: A critical appraisal
5. Free radical damage, iron, and Alzheimer's disease
6. Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis
7. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease
8. P53- and CD95-associated apoptosis in neurodegeneratire diseases
9. Bax protein expression is increased in Alzheimer's brain: Correlations with DNA damage. Bcl-2 expression, and brain pathology
10. Preliminary results of the study of neuronal death and the expression of bcl-2 protein in Alzheimer's disease
11. Reactive oxygen and DNA damage in mitochondria
12. Oxidative damage to mitochondrial DNA and its relationship to ageing
13. Mitochondrial DNA damage as a mechanism of ceil loss in Alzheimer's disease
14. Tau as a marker for Alzheimer's disease
15. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5
16. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells
17. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5
18. Evidence for cdk5 as a major activity phosphorylating tau protein in porcine brain extract
19. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
20. Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain
21. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
22. Phosphorylation of retinoblastoma protein at apoptotic cell death in rat neuroblastoma B50 cells
23. Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death
24. Over-expression of nitric oxide synthase-3 and free radical injury cause apoptosis and phsopho-tau accumulation in neuronal cells
25. The cdk5/p35 kinase is essential for neurite out-growth during neuronal differentiation
26. Measurement and characterization of free radical generation in reoxygenated human endothelial cells
27. Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents
28. Superoxide anion is a natural inhibitor of FAS-mediated cell death
29. Microtiter immunocytochemical ELISA assay: A novel and highly sensitive method of quantifying immunoreactivity
30. Profiles of neuronal thread protein expression in Alzheimer's disease
31. Modulation of neuronal thread protein expression with neuritic sprouting: Relevance to Alzheimer's disease
32. Neuronal thread protein gene modulation with cerebral infarction
33. Characterization of the AD7c-NTP cDNA expression in Alzheimer's disease and measurement of the 41-kD protein in cerebrospinal fluid
34. Bcl-2 and Bax protein expression in Alzheimer's disease
35. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus
36. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease
37. Expression of ced-3 and ced-9 homologs in Alzheimer's s disease cerebral cortex
38. Down-regulation of mammalian mitochondrial RNAs during oxidative stress
39. Oxidative stress causes a general, calcium-dependent degradation of mitochondrial polynucleotides
40. 16S mitochondrial ribosomal RNA degradation is associated with apoptosis
41. GAP-43: An intrinsic determinant of neuronal development and plasticity
42. GAP-43 gene expression during development: Persistence in a distinctive set of neurons in the mature central nervous system
43. Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease
44. Patterns of aberrant sprouting in Alzheimer's disease